Detalhe da pesquisa
1.
Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid ß aggregation for Alzheimer's disease therapy.
Heliyon
; 10(1): e23563, 2024 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38223723